Continued expansion of COVID-19 product portfolio to address unmet market needs
Paris, France and Camberley, UK – 16 November 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an R&D update.
http://novacyt.com/wp-content/uploads/2020/11/Novacyt-RD-Update-16-11-20-ENGLISH.pdf